Who owns BENEFICIENT?

Tip: Access positions for across all investors

Analyze quarterly positions in Beneficient with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Beneficient stock

Who bought or sold BENEFICIENT this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Highbridge Capital Management 3.1M $22M 8% Mar 2024
 View chart
Citadel Advisors 906k $8.8k 0% Mar 2024
 View chart
MMCAP International Inc. SPC 750k $5.4k 0% Mar 2024
 View chart
Yakira Capital Management 750k $6.1k 0% Mar 2024
 View chart
Rivernorth Capital Management 563k $5.6k 0% Mar 2024
 View chart
LMR Partners 488k $3.5k 0% Mar 2024
 View chart
CVI Holdings 408k $2.9k -1% Mar 2024
 View chart
Goldman Sachs Group 380k $2.7k 0% Mar 2024
 View chart
Exos TFP Holdings 367k $3.7k 0% Dec 2023
 View chart
Exos Asset Management 367k $2.6k 100% Mar 2024
 View chart
Cowen And Company 350k $2.5k 0% Mar 2024
 View chart
Hudson Bay Capital Management 300k $2.9k 0% Mar 2024
 View chart
Tenor Capital Management 300k $2.2M 0% Mar 2024
 View chart
Context Capital Management 210k $21.002400 0% Mar 2024
 View chart
Q Global Advisors 190k $1.0k 0% Mar 2024
 View chart
Calamos Advisors 188k $1.5k 0% Mar 2024
 View chart
Clear Street 171k $1.0k 0% Mar 2024
 View chart
Marshall Wace 170k $790k -11% Mar 2024
 View chart
Walleye Trading Advisors 128k $920.440800 0% Mar 2024
 View chart
Warberg Asset Management 104k $855.957000 0% Mar 2024
 View chart
Empyrean Capital Partners 100k $820.000000 0% Mar 2024
 View chart
Crystalline Management 86k $621.000000 0% Mar 2024
 View chart
Walleye Trading 72k $517.737600 0% Mar 2024
 View chart
Millennium Management 68k $486.000000 0% Mar 2024
 View chart
Cruiser Capital Advisors 49k $380.250000 0% Mar 2024
 View chart
Wolverine Asset Management 22k $160.092000 0% Mar 2024
 View chart
D. E. Shaw & Co 20k $189.150000 0% Mar 2024
 View chart
Ancora Advisors 17k $119.088300 0% Mar 2024
 View chart
UBS Group 11k $75.712000 100% Mar 2024
 View chart
Ausdal Financial Partners 10k $71.000000 0% Mar 2024
 View chart
Tower Research Capital 77.00 $1.001000 0% Mar 2024
 View chart

Who sold out of Beneficient?

Fund or Company Name Date Sold Shares Held Valued At
K2 Principal Fund Sep 2023 223k $8.6k